Alma Therapeutics - Next Generation Oral Biologics Delivery
BiotechnologyView the employees at
Alma Therapeutics - Next Generation Oral Biologics Delivery-
Anat Raz Chief Scientific Officer at Alma Therapeutics
-
Kfar Sava, Center District, Israel
-
Top 1%
Oz C. Owner and CEO at OZCA Engineering-
Top 10%
Lynn Cohen Materials engineering and Chemistry student at Tel Aviv University-
Tel Aviv-Yafo, Tel Aviv District, Israel
-
Rising Star
David Ronder Chief Operating Officer-
Israel
-
Top 5%
Overview
Alma Therapeutics is developing a novel drug delivery platform for the oral delivery of complex molecules and biologics such as: Peptides, Proteins and Antibodies
-